Key facts
- This page summarizes Markus Sieger's Form 4 filing for Cyclo Therapeutics, Inc. (CYTH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Mar 2022, 10:28.
Markus Sieger - 29 Mar 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)
- Reporting relationship
- Director
- Issuer ticker
- CYTH
- Reported as of
- 29 Mar 2022
- Net transaction value
- +$27,300
- SEC form
- 4
- Accepted by SEC
- 30 Mar 2022, 10:28:07 UTC
- Prior SEC filing
- 01 Feb 2022
- Next SEC filing
- 04 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Markus Sieger
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Markus Sieger filed Form 4 for Cyclo Therapeutics, Inc. (CYTH) on 30 Mar 2022.
Change
- Previous filing in this sequence was filed on 01 Feb 2022.
- Current net transaction value: +$27,300.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYTH
transaction
Common Stock
Purchase
- Transaction value
- $27,300
- Shares
- +10,000
- Change %
- +14%
- Price
- $2.73
- Shares after
- 81,689
- Date
- 29 Mar 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.